- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05804552
The Effect of Dorsal Genital Nerve Stimulation on Opening Urethral Pressure
November 28, 2023 updated by: Thea Christoffersen
This study aims to investigate the effect of electrical stimulation of the dorsal genital nerve on the urethral pressure in healthy women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark, 2400
- Zelo Phase 1 unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Normal weight (Body weight 50 kg or more, Body Mass Index 18-5-30 kg/m2)
- Signed an informed consent
Exclusion Criteria:
Any history of clinically significant diseases, unless regarded irrelevant and/or stable by the investigator
- Any history or evidence of clinically significant urinary incontinence, urinary retention, overactive bladder, or other voiding dysfunction
- Known or suspected nerve injuries or paraesthesia in the pelvic area
- Pregnancy within six months before enrolment
- Breastfeeding within three months before enrolment
- Smoking or other regular use of any form of nicotine product during the study period and the previous 3 months
- Current or prior participation (within 3 months before screening) in other clinical trials that might affect the results of this study (judged by the investigator)
- Any systemic drug use within 2 weeks before the first study day (prescription drugs, over-the-counter drugs, herbal drugs, and/or illicit drugs), except for occasional use of paracetamol (up to 4 g/day), ibuprofen, or antihistamine, hormonal contraceptives and hormone replacement therapy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dorsal genital nerve stimulation
|
Two types of stimulation electrodes will be used: UCon Patch Electrodes (InnoCon Medical ApS, Denmark) and ValuTrodes/EconoStim Electrodes (5x5 cm, Axelgaard Manufacturing Co. Ltd., United States).
The UCon Patch Electrode acts as a cathode and will be placed on the clitoris.
The ValuTrode/EconoStim acts as an anode and will be placed on the lower abdomen.
The continuous stimulation consists of a train of single pulses provided continuously with a frequency of 20 Hz and a pulse duration of 200 μs.
The burst stimulus pattern consists of a train of bursts.
The length of the train is 10 s and will consist of 20-30 bursts/s.
One burst consists of 5 identical square pulses (monophasic).
The inter-pulse interval is 4 ms (time between the onset of 2 consecutive pulses) while a pulse duration of 200 μs will be used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of burst dorsal genital nerve stimulation compared to baseline
Time Frame: Baseline and during dorsal genital nerve stimulation
|
The difference in mean opening urethral pressure (in cmH20) measured with urethral pressure reflectometry during electrical burst stimulation of dorsal genital nerve (reflex-induced pelvic floor contraction) compared to mean baseline opening urethral pressure during squeezing condition
|
Baseline and during dorsal genital nerve stimulation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of continuous dorsal genital nerve stimulation on resting pressure compared to baseline
Time Frame: Baseline and during dorsal genital nerve stimulation
|
The difference in mean opening urethral pressure (in cmH20) measured with urethral pressure reflectometry during maximal tolerated continuous dorsal genital nerve stimulation compared to mean baseline OUP (resting condition).
|
Baseline and during dorsal genital nerve stimulation
|
|
Effect of continuous dorsal genital nerve stimulation on squeezing pressure compared to baseline
Time Frame: Baseline and during dorsal genital nerve stimulation
|
The difference in mean opening urethral pressure (in cmH20) measured with urethral pressure reflectometry during maximal tolerated continuous dorsal genital nerve stimulation compared to mean baseline opening urethral pressure (squeezing condition).
|
Baseline and during dorsal genital nerve stimulation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 28, 2023
Primary Completion (Actual)
March 30, 2023
Study Completion (Actual)
March 30, 2023
Study Registration Dates
First Submitted
March 27, 2023
First Submitted That Met QC Criteria
March 27, 2023
First Posted (Actual)
April 7, 2023
Study Record Updates
Last Update Posted (Actual)
November 29, 2023
Last Update Submitted That Met QC Criteria
November 28, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-22063824
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress Urinary Incontinence
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
-
University Magna GraeciaUnknownStress Urinary IncontinenceItaly
-
University of California, IrvineWithdrawnStress Urinary IncontinenceUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Stress IncontinenceUnited States
-
GT Urological, LLCCompletedMale Stress Urinary IncontinenceAustralia, Czechia, New Zealand
Clinical Trials on Dorsal genital nerve stimulation
-
University College, LondonRoyal National Orthopaedic Hospital NHS TrustActive, not recruitingSpinal Cord Injuries | Neurogenic Bladder | Neurogenic Detrusor Overactivity | Neurogenic Bladder DysfunctionUnited Kingdom
-
InnoCon MedicalOdense University Hospital; Aarhus University Hospital; Herlev HospitalRecruitingUrinary Incontinence | Fecal Incontinence | Urinary Incontinence, Urge | Nocturia | Fecal Incontinence With Fecal Urgency | Urinary Frequency More Than Once at Night | Incontinence, Nighttime Urinary | Bowel Disorders FunctionalDenmark
-
VA Office of Research and DevelopmentSyracuse VA Medical CenterCompletedNeurogenic Bladder DysfunctionUnited States
-
MetroHealth Medical CenterCongressionally Directed Medical Research ProgramsRecruiting
-
University of MichiganThe Craig H. Neilsen Foundation; International Society for the Study of Women...CompletedSpinal Cord Injuries | Female Sexual DysfunctionUnited States
-
University of MichiganThe Craig H. Neilsen Foundation; International Society for the Study of Women...CompletedFemale Sexual Dysfunction | Female Sexual Dysfunction Due to Physical ConditionUnited States
-
Prof. Dr. med. Marc PossoverUnknownBladder, OveractiveSwitzerland
-
MetroHealth Medical CenterCongressionally Directed Medical Research Programs; VA of Northeast Ohio Health...RecruitingFecal IncontinenceUnited States
-
Prof. Dr. med. Marc PossoverNot yet recruitingErectile DysfunctionSwitzerland
-
Skolkovo Institute of Science and TechnologyMotorica LLC; The Federal Center of Brain Research and NeurotechnologiesRecruitingPhantom Limb PainRussian Federation